Insider · CIK 0001145911

KELLERMAN DONALD J

Reports to the SEC for 4 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001145911

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-31	Zosano Pharma CorpS Sale	VP, Clinical Dev & Med Affairs	SSale	−4,006 sh	$0.21	−$841.661	56,331
2021-10-15	Zosano Pharma CorpA Award	VP, Clinical Dev & Med Affairs	AAward	+10K sh	—	—	60,337
2021-10-15	Zosano Pharma CorpStock Option (Right to Buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+20K sh	—	—	20,000
2021-06-04	Zosano Pharma CorpS Sale	VP, Clinical Dev & Med Affairs	SSale	−1,709 sh	$0.81	−$1,375.745	50,337
2021-03-30	Zosano Pharma CorpStock Option (Right to Buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+65K sh	—	—	65,000
2021-03-30	Zosano Pharma CorpA Award	VP, Clinical Dev & Med Affairs	AAward	+32.5K sh	—	—	52,046
2020-06-25	Zosano Pharma CorpA Award	VP, Clinical Dev & Med Affairs	AAward	+18.8K sh	—	—	19,546
2020-06-03	Zosano Pharma CorpStock Option (right to buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+37.5K sh	—	—	37,500
2019-06-11	Zosano Pharma CorpEmployee Stock Option (right to buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+30K sh	—	—	30,000
2019-06-11	Zosano Pharma CorpEmployee Stock Option (right to buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+30K sh	—	—	30,000
2018-05-31	Zosano Pharma CorpEmployee Stock Option (right to buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+100K sh	—	—	100,000
2017-05-31	Zosano Pharma CorpEmployee Stock Option (right to buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+180K sh	—	—	180,000
2017-04-10	Zosano Pharma CorpEmployee Stock Option (right to buy)A Award	VP, Clinical Dev & Med Affairs	AAward	+15K sh	—	—	15,000
2016-08-19	Zosano Pharma CorpSeries B Warrants (right to buy)P Purchase	VP, Clinical Dev & Med Affairs	PPurchase	+15.9K sh	$0.13	+$1,990	15,920
2016-08-19	Zosano Pharma CorpSeries A Warrants (right to buy)P Purchase	VP, Clinical Dev & Med Affairs	PPurchase	+15.9K sh	$0.13	+$1,990	15,920
2016-08-19	Zosano Pharma CorpP Purchase	VP, Clinical Dev & Med Affairs	PPurchase	+15.9K sh	$1.32	+$21K	15,920
2014-10-29	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	See Remarks	AAward	+36K sh	—	—	36,000
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−29.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.U Disposition from Tender	SVP,Clinical Dev & Med Affairs	UDisposition from Tender	−3,795 sh	$25.00	−$94.9K	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−61.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−55K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−27.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−32.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−4,500 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−8,250 sh	—	—	0
2013-02-01	MAP Pharmaceuticals, Inc.S Sale	SVP,Clinical Dev & Med Affairs	SSale	−1,429 sh	$24.73	−$35.3K	3,479
2013-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	+2,250 sh	—	—	5,779
2013-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	SVP,Clinical Dev & Med Affairs	FTax Payment	−871 sh	$24.75	−$21.6K	4,908
2013-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	−2,250 sh	—	—	4,500
2013-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	−2,750 sh	—	—	8,250
2013-01-25	MAP Pharmaceuticals, Inc.F Tax Payment	SVP,Clinical Dev & Med Affairs	FTax Payment	−1,207 sh	$24.75	−$29.9K	3,529
2013-01-25	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	+2,750 sh	—	—	4,736
2012-11-20	MAP Pharmaceuticals, Inc.J Other	SVP,Clinical Dev & Med Affairs	JOther	+557 sh	$9.89	+$5,510.958	1,986
2012-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	−2,250 sh	—	—	6,750
2012-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	+2,250 sh	—	—	2,372
2012-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	SVP,Clinical Dev & Med Affairs	FTax Payment	−943 sh	$13.84	−$13.1K	1,429
2012-01-25	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP,Clinical Dev & Med Affairs	AAward	+32.5K sh	—	—	32,500
2012-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	SVP,Clinical Dev & Med Affairs	AAward	+11K sh	—	—	11,000
2011-12-02	MAP Pharmaceuticals, Inc.D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−3,000 sh	$13.62	−$40.9K	122
2011-08-24	MAP Pharmaceuticals, Inc.D Disposition to Issuer	SVP,Clinical Dev & Med Affairs	DDisposition to Issuer	−4,000 sh	$12.34	−$49.4K	3,122
2011-08-04	MAP Pharmaceuticals, Inc.F Tax Payment	SVP,Clinical Dev & Med Affairs	FTax Payment	−4,128 sh	$13.43	−$55.4K	7,122
2011-08-04	MAP Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	−11.3K sh	—	—	7,122
2011-08-04	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP,Clinical Dev & Med Affairs	MExercise/Conversion	+11.3K sh	—	—	11,250
2011-01-26	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP,Clinical Dev & Med Affairs	AAward	+27.5K sh	—	—	27,500
2011-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	SVP,Clinical Dev & Med Affairs	AAward	+9,000 sh	—	—	9,000
2010-02-02	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	SVP,Clinical Dev & Med Affairs	AAward	+22.5K sh	—	—	22,500
2010-02-02	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP,Clinical Dev & Med Affairs	AAward	+55K sh	—	—	55,000
2009-02-11	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP,Clinical Dev & Med Affairs	AAward	+35K sh	$10.37	+$363K	35,000
2008-07-23	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP,Clinical Dev & Med Affairs	AAward	+40K sh	—	—	0
2008-07-23	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP,Clinical Dev & Med Affairs	AAward	+80K sh	—	—	0

Recent filings

Accepted (ET)
Apr 14
KELLERMAN DONALD J0001567619-22-007910
SEC(opens sec.gov)
Oct 194
KELLERMAN DONALD J0001567619-21-018474
SEC(opens sec.gov)
Jun 74
KELLERMAN DONALD J0001567619-21-011788
SEC(opens sec.gov)
Apr 14
KELLERMAN DONALD J0001567619-21-007413
SEC(opens sec.gov)
Jun 294
KELLERMAN DONALD J0001140361-20-015092
SEC(opens sec.gov)
Jun 54
KELLERMAN DONALD J0001567619-20-011802
SEC(opens sec.gov)
Jun 194/A
KELLERMAN DONALD J0001567619-19-013713
SEC(opens sec.gov)
Jun 134
KELLERMAN DONALD J0001567619-19-013328
SEC(opens sec.gov)
Jun 14
KELLERMAN DONALD J0001587221-18-000020
SEC(opens sec.gov)
Apr 274
KELLERMAN DONALD J0001587221-18-000013
SEC(opens sec.gov)
Apr 124
Zosano Pharma Corp0001587221-17-000012
SEC(opens sec.gov)
Aug 224
Zosano Pharma Corp0001145911-16-000005
SEC(opens sec.gov)
Nov 34
Tonix Pharmaceuticals Holding Corp.0001144204-14-064544
SEC(opens sec.gov)
Mar 44
KELLERMAN DONALD J0001181431-13-014238
SEC(opens sec.gov)

Companies

Address

C/O MAP PHARMACEUTICALS, INC. 2400 BAYSHORE PARKWAY, SUITE 200

MOUNTAIN VIEW, CA, 94043